Cargando…

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no known effective prophylaxis. We investigated whether hydroxychloroquine could prevent SARS-CoV-2 in healthcare workers at high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajasingham, Radha, Bangdiwala, Ananta S, Nicol, Melanie R, Skipper, Caleb P, Pastick, Katelyn A, Axelrod, Margaret L, Pullen, Matthew F, Nascene, Alanna A, Williams, Darlisha A, Engen, Nicole W, Okafor, Elizabeth C, Rini, Brian I, Mayer, Ingrid A, McDonald, Emily G, Lee, Todd C, Li, Peter, MacKenzie, Lauren J, Balko, Justin M, Dunlop, Stephen J, Hullsiek, Katherine H, Boulware, David R, Lofgren, Sarah M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665393/ https://www.ncbi.nlm.nih.gov/pubmed/33068425 http://dx.doi.org/10.1093/cid/ciaa1571

Ejemplares similares

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic
por: Pullen, Matthew F, et al.
Publicado: (2020)

Symptoms of COVID-19 Outpatients in the United States
por: Pullen, Matthew F, et al.
Publicado: (2020)

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials
por: Lofgren, Sarah M, et al.
Publicado: (2021)

Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
por: Lofgren, Sarah M, et al.
Publicado: (2020)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
por: Lother, Sylvain A., et al.
Publicado: (2020)

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
por: Skipper, Caleb P., et al.
Publicado: (2020)

Evaluation of the effectiveness of a South African laboratory cryptococcal antigen screening programme using a retrospective cohort and a cluster-randomised trial design
por: DeSanto, Daniel J, et al.
Publicado: (2022)

A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19—A Call for Clinical Trials
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2020)

Tuberculous meningitis diagnosis and outcomes during the Xpert MTB/Rif era: a 6.5-year cohort study in Uganda
por: Cresswell, Fiona V., et al.
Publicado: (2018)

Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis
por: Okafor, Elizabeth C., et al.
Publicado: (2020)

Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis
por: Martyn, Emily M, et al.
Publicado: (2020)

1716. Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis
por: Nicol, Melanie R., et al.
Publicado: (2019)

Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014)

Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes
por: Pastick, Katelyn A, et al.
Publicado: (2019)

Technical procedures and REDCap tools for internet-based clinical trials
por: Bangdiwala, Ananta S., et al.
Publicado: (2022)

2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda
por: Lofgren, Sarah M., et al.
Publicado: (2018)

1374. Clinical Outcomes of Sepsis According to Race at University of Minnesota Medical Center
por: Meyer-Mueller, Cameron, et al.
Publicado: (2021)

The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2014)

Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV
por: Ellis, Jayne, et al.
Publicado: (2023)

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Erratum to: The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection
por: Mpoza, Edward, et al.
Publicado: (2018)

Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients
por: Kwizera, Richard, et al.
Publicado: (2019)

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
por: Skipper, Caleb P, et al.
Publicado: (2022)

Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016
por: Flynn, Andrew G., et al.
Publicado: (2017)

Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation
por: Rhein, Joshua, et al.
Publicado: (2018)

Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2015)

Differences in Reasons for Late Presentation to HIV Care in Uganda Among Men and Women
por: Lofgren, Sarah M., et al.
Publicado: (2022)

Routine Cryptococcal Antigen Screening in Solid Organ Transplant Recipients: Is it Time to Save Lives and Money?
por: George, Ige, et al.
Publicado: (2017)

88462 Fluconazole distribution in CNS and gynecological tissues in HIV-related cryptococcal meningitis decedents
por: Nicol, Melanie R., et al.
Publicado: (2021)

Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda
por: Namuju, Olivie C., et al.
Publicado: (2022)

1472 Epidemiology of Meningitis in an HIV-infected Ugandan Cohort
por: Rajasingham, Radha, et al.
Publicado: (2014)

Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Rajasingham, Radha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gho9sp09j6mc5qtrikl1eoi8qu